Remote monitoring vs standard care for IBD patients starting new treatment
Part of Digestive system clinical trials.
This trial tests whether using a remote monitoring app (GutyCare) helps people with Crohn's disease or ulcerative colitis better manage their condition when starting or changing advanced therapy. Participants will either use the app or receive standard care to see which approach leads to better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with Crohn's disease or ulcerative colitis for at least 3 months.
- You are about to start a new advanced therapy (like a biologic or small molecule drug) or make a major change to your current treatment.
- Your IBD must be active (causing symptoms).
- You must not have major abdominal surgery that changed your intestines (like a stoma or large resection), an uncontrolled abscess, or active perianal disease.
- You must not need digestive surgery during the study period.
- You must be able and willing to use the GutyCare app, and not already using it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with Crohn's disease, ulcerative colitis, or unclassified IBD to better understand the links between these conditions, cancer, and serious infections. It asks you to share personal details and complete online surveys over time.
This study tests whether people with inflammatory bowel disease (IBD) can be safely monitored from home instead of visiting the hospital every few months. It uses a smartphone app and home tests to check your condition, with fewer in-person visits.
This study uses a smartphone app and activity tracker to monitor how people with Crohn's disease, ulcerative colitis, or unspecified IBD feel day to day. It may help doctors better understand and manage your condition through digital health data.
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
This trial tests if regular video check-ins via phone or computer can help people with IBD stick to their medications and feel better emotionally. You would use a messaging app and video calls to stay in touch with your care team from home.
This trial tests whether “treat-to-target” care—guided by regular symptom checks, telemonitoring, and patient education—works better than standard follow-up when starting adalimumab for ulcerative colitis. It aims to help control inflammation more effectively and reduce flare-ups.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.